Calidi Biotherapeutics, Inc. (CLDI) is a publicly traded Healthcare sector company. As of May 21, 2026, CLDI trades at $0.17 with a market cap of $2.79M and a P/E ratio of -0.03. CLDI moved -8.04% today. Year to date, CLDI is -85.53%; over the trailing twelve months it is -96.84%. Its 52-week range spans $0.16 to $46.68. Rallies surfaces CLDI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CLDI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLDI recently traded at $0.17. Market cap is $2.79M. P/E ratio is -0.03. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $0.17 |
| Market Cap | $2.79M |
| P/E Ratio | -0.03 |
| EPS | $-5.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.68 |
| 52-Week Low | $0.16 |
| Volume | 231.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-20.06M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-20.06M | $-5.95 |
| 2024 | $0 | $-22.21M | $-2.97 |
| 2023 | $0 | $-29.22M | $1.73 |
CLDI analyst coverage data. Average price target: $0.00.